31 March 2025 With billions in revenue at stake, the pharma giant has a 27-country parallel litigation effort to protect its blockbuster blood thinner from generics. Marisa Woutersen finds Bayer’s ...

After almost 30 years as head of IP at Bayer, Jörg Thomaier is to retire and is handing the baton to Dorian Immler. Speaking ...

This LSPN panel features experts from Maiwald, Regeneron, Vertex Pharmaceuticals, and Taylor Wessing discussing the impact of ...

Janssen filed patent infringement suits in New Jersey and Delaware over proposed copy of blockbuster drug Invega Sustenna | Lawsuits follow appeals court win for J&J in separate action with Teva and ...

The Arusha Protocol is a catalyst for agricultural transformation. It provides legal assurance and financial incentives for plant breeders, enabling access to improved, protected varieties that ...

For startups, getting a drug to market is a marathon but founders need to think beyond filing patents to win over investors, ...

4 February 2025 LSIPR sister title WIPR releases USA Patents Rankings, divided into categories of non-contentious and ...

If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article ...

LSPN panellists from Mathys & Squire discuss recent developments affecting the EPO Boards of Appeal and decisions emerging ...

Disputed drug forms part of a multi-billion dollar franchise for J&J, ranking among its largest revenue drivers in mental health treatment | Appeals court rejects arguments that patent claims would ...

Major team hire by premier European litigation firm | September opening adds to successful UPC practice | Hire is a ‘landmark’ moment says Penny Gilbert. Already registered? If you don't have a login ...